NCT05554354 2026-03-03Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)National Cancer Institute (NCI)Phase 2 Terminated1 enrolled
NCT03801369 2026-02-25AMTEC IIT: Phase 2 Multiarm Study in TNBCOHSU Knight Cancer InstitutePhase 2 Terminated24 enrolled 16 charts